Best Alkylating Drug for leukemia, myelogenous, chronic, bcr-abl positive
2 Alkylating Drug drugs indicated for leukemia, myelogenous, chronic, bcr-abl positive, ranked by our independent rating. The current highest-rated is myleran. Compare them with all treatments for leukemia, myelogenous, chronic, bcr-abl positive or the full Alkylating Drug class. Not medical advice — always consult a professional.
Top alkylating drug for leukemia, myelogenous, chronic, bcr-abl positive: 1. Myleran · 2. Busulfex
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Myleran | Not yet rated | Prescription | — | View → |
| 2 | Busulfex | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best alkylating drug for leukemia, myelogenous, chronic, bcr-abl positive?
- By our independent rating, myleran currently ranks highest among Alkylating Drug drugs used for leukemia, myelogenous, chronic, bcr-abl positive. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which alkylating drug drugs treat leukemia, myelogenous, chronic, bcr-abl positive?
- pharmaranks lists 2 Alkylating Drug products indicated for leukemia, myelogenous, chronic, bcr-abl positive, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.